Article Public (all visitors)

Making New Drugs With a Dose of Artificial Intelligence - The New York Times

NYTIMES 2019

Researchers at DeepMind, owned by Google’s parent company, and other companies are applying their powerful A.I. systems to drug discovery research.

Curated by

FoundryBase

Updated 5 days ago

Browse more

View all Articles

Continue from source

More from source

Browse more from nytimes.com

Contribute to FoundryBase

Found something worth adding?

Sign in to suggest resources and start building your own collection.